Literature DB >> 7316453

Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides.

A R MacLean, K H Outch, J M Russell, J B Brown, P M Dennis.   

Abstract

To increase the sample-handling capacity for an induction of ovulation programme, direct urinary radioimmunoassays (RIA) for three steroid glucuronides, pregnanediol-3-glucuronide (Pd-3-G), oestrone-3-glucuronide (E1-3-G), and oestriol-16 alpha-glucuronide (E3-16-G), were established. Results obtained for urinary Pd-3-G measured by direct RIA show an excellent correlation (r = 0.98, N = 46) with those for urinary pregnanediol measured by gas-liquid chromatography. Estrone-3-glucuronide (E1-3-G) and estriol-16 alpha-glucuronide (E3-16-G) values, measured by direct RIA, closely paralleled the total urinary oestrogen measured fluorimetrically. Ovarian response to ovulation induction therapy can be monitored by observing the changes in the levels of E1-3-G in urine. Pre-ovulatory levels of urinary E3-16-G were found to be too low for use in this regard. Direct RIA for E1-3-G and Pd-3-G are recommended as reliable indices of ovarian function in the monitoring of patients receiving treatment for the induction of ovulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316453     DOI: 10.1177/000456328101800604

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Automation and limitation of 17 beta oestradiol dehydrogenase in monitoring ovarian function.

Authors:  D L Hay; G F Ibrahim; I Horacek
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

Review 2.  Self-Monitoring of Urinary Hormones in Combination with Telemedicine - a Timely Review and Opinion Piece in Medically Assisted Reproduction.

Authors:  Roger J Hart; Thomas D'Hooghe; Eline A F Dancet; Ramón Aurell; Bruno Lunenfeld; Raoul Orvieto; Antonio Pellicer; Nikolaos P Polyzos; Wenjing Zheng
Journal:  Reprod Sci       Date:  2021-11-15       Impact factor: 2.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.